FDA Reconstitutes Key Peripheral and Central Nervous System Drugs Advisory Committee
The U.S. Food and Drug Administration (FDA) has announced plans to re-establish the Peripheral and Central Nervous System Drugs Advisory Committee, which was dissolved on June 4 by Acting Commissioner. The committee will be reconstituted following a notice published in the Federal Register.
Topics: advisory committee FDA government action